PETRA ACQUISITION INC (PAICU) Stock News

Respiratory Viral Infections-Focused Revelation Biosciences Turns To SPAC Deal For NASDAQ Debut

Revelation Biosciences Inc is joining Petra Acquisition Inc (NASDAQ: PAIC) to create a NASDAQ-listed company with an enterprise value of $128 million....

Mentions: PAIC

Revelation Biosciences, Inc., a Life Sciences Company Developing Therapeutics and Diagnostics for Respiratory Viral Infections, Including COVID-19, to Become Publicly Traded Through a Merger with Petra Acquisition, Inc.

Mentions: PAIC

Petra Acquisition prices $70M IPO (NASDAQ:PAICU)

Cannabis SPAC Petra Acquisition (NASDAQ:PAICU) has priced its initial public offering of 7M units at $10/unit.Each unit consists of one common share and one warrant, exercisable to purchase one common share at $11.50.Underwriters' over-allotment is an additional 1.05M units.The company is led by technology veteran Andreas Typaldos and Sean Fitzpatrick, the founder and Managing Partner of Fidem Advisors.Offering is expected to close on or about Oct.